CH589669A5 - - Google Patents

Info

Publication number
CH589669A5
CH589669A5 CH1159273A CH1159273A CH589669A5 CH 589669 A5 CH589669 A5 CH 589669A5 CH 1159273 A CH1159273 A CH 1159273A CH 1159273 A CH1159273 A CH 1159273A CH 589669 A5 CH589669 A5 CH 589669A5
Authority
CH
Switzerland
Application number
CH1159273A
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of CH589669A5 publication Critical patent/CH589669A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • C07J5/0038—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
CH1159273A 1972-08-11 1973-08-10 CH589669A5 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3765672A GB1440064A (en) 1972-08-11 1972-08-11 Delta8-9- steroids of the pregnane series

Publications (1)

Publication Number Publication Date
CH589669A5 true CH589669A5 (ja) 1977-07-15

Family

ID=10398038

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1159273A CH589669A5 (ja) 1972-08-11 1973-08-10

Country Status (17)

Country Link
US (1) US3845085A (ja)
JP (1) JPS4985061A (ja)
AU (1) AU474366B2 (ja)
BE (1) BE803462A (ja)
CA (1) CA1016535A (ja)
CH (1) CH589669A5 (ja)
DE (1) DE2340656A1 (ja)
DK (1) DK134816B (ja)
ES (1) ES417737A1 (ja)
FR (1) FR2195452B1 (ja)
GB (1) GB1440064A (ja)
IE (1) IE38074B1 (ja)
IL (1) IL42943A (ja)
LU (1) LU68210A1 (ja)
NL (1) NL7311070A (ja)
PH (1) PH9642A (ja)
SE (1) SE396952B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2448662C2 (de) * 1974-10-09 1983-07-21 Schering Ag, 1000 Berlin Und 4619 Bergkamen 6α-Fluor-16α-methyl-1,4,8-pregnatrien-3,20-dion-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US4225597A (en) * 1976-10-01 1980-09-30 Schering Corporation Beclomethasone dipropionate-hexane solvate and aerosols prepared therefrom
DE2645104C2 (de) * 1976-10-04 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen 11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung
NL7802905A (nl) * 1977-04-21 1978-10-24 Hoffmann La Roche Werkwijze voor het bereiden van d-homosteroiden.
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
JPS5653700A (en) * 1979-10-09 1981-05-13 Mitsubishi Chem Ind Ltd Production of 9alpha-chloro-11beta-hydroxy-corticosteroid
JP7095304B2 (ja) 2018-02-15 2022-07-05 株式会社リコー 分光特性取得装置、画像形成装置、画像形成システム、画像形成装置の管理システム、及び画像形成装置の管理方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1026160A (en) * 1964-04-29 1966-04-14 American Cyanamid Co Pregnatrienes

Also Published As

Publication number Publication date
DE2340656A1 (de) 1974-02-28
BE803462A (fr) 1974-02-11
IE38074L (en) 1974-02-11
SE396952B (sv) 1977-10-10
NL7311070A (ja) 1974-02-13
CA1016535A (en) 1977-08-30
AU474366B2 (en) 1976-07-22
LU68210A1 (ja) 1973-10-16
IL42943A (en) 1978-04-30
FR2195452B1 (ja) 1976-08-13
JPS4985061A (ja) 1974-08-15
PH9642A (en) 1976-01-26
US3845085A (en) 1974-10-29
ES417737A1 (es) 1976-02-16
AU5914273A (en) 1975-02-13
DK134816B (da) 1977-01-24
FR2195452A1 (ja) 1974-03-08
IE38074B1 (en) 1977-12-21
IL42943A0 (en) 1973-11-28
GB1440064A (en) 1976-06-23
DK134816C (ja) 1977-08-15

Similar Documents

Publication Publication Date Title
JPS498431A (ja)
JPS5411040B2 (ja)
FR2195452B1 (ja)
JPS4942602A (ja)
FR2185797B1 (ja)
JPS523295B2 (ja)
JPS4955654A (ja)
JPS4952337U (ja)
JPS4957631U (ja)
JPS5620Y2 (ja)
JPS4985624U (ja)
JPS4915416U (ja)
JPS49107776U (ja)
JPS4960613A (ja)
JPS4965942U (ja)
FR2213233B1 (ja)
JPS5232430Y2 (ja)
JPS48106458U (ja)
JPS4890260U (ja)
JPS4917684U (ja)
JPS4951830U (ja)
JPS4987196U (ja)
JPS4999152U (ja)
CH567695A5 (ja)
CH569088A5 (ja)

Legal Events

Date Code Title Description
PL Patent ceased